Tag Archives: HCV

Biotech Rally Update… up 12.9% in 30 Days: ACHN, CLDX, FBT, KPTI

Rayno Biopharmaceutical Stocks- Including New Picks Another great day for biotech with most Rayno stocks in a rally mode with a bit of profit taking on Gilead Sciences(GILD) down 1%. Notable movers up on our core picks are: Alkermes (ALKS), Amgen (AMGN), Ariad (ARIA), Regeneron (REGN) and Vertex (VRTX).Our top small cap pick Achillion (ACHN) […]

Leave a comment Continue Reading →

Look For Biotech Rally Today Sparked By Merck $3.9B Acquisition of Idenix… Update-1

Update-1…. 45 Minutes Before the Close 6/9…Risk On Biotech stocks soared today right at the open after news of $3.9B Idenix deal news was out. The XBI was up 5.4% on good volume. The XBI is more equal weighted and sensitive to mid and small cap stock moves.The PBE another more speculative ETF was up 7.5%. […]

Comments Off Continue Reading →

Rayno Dx and Tools 2014 YTD After Correction: ILMN, HOLX, RHHBY

April Sell-Off Hit Diagnostic Small and Mid Caps The bursting of the biotech bubble affected many small cap growth stocks. 2013 was a great year for our portfolio so some weakness was expected after the huge Q1 2014 moves. Most of our picks peaked in Jan/Feb time frame when many of our favorites were hit […]

Comments Off Continue Reading →

Rayno Biopharmaceutical Stocks Q1 2014 Performance

Rayno Biopharmaceutical Portfolio 3/31/14 Most of our biotech picks did well in a tough quarter that went through a severe correction in early February and again in late March. Many small and mid-cap momentum stocks were crushed but indices (FBT,IBB) overall held the early February technical levels. Use the two ETFs and FBIOX for re-balancing […]

Comments Off Continue Reading →

Large Cap Biopharmaceutical Stocks Will Lead The Way Up

Large Cap Biopharmaceutical Growth Stocks  With the MoMo days over the next earnings cycle (Q1,Q2 2014) should give us better clarity on winners for 2014.On the last day of March all of these large caps rallied after a severe one week correction from 3/21-28. Watch the technicals this week for bargain hunting, for example, Amgen, […]

Comments Off Continue Reading →

Biotech Stocks Holding At February Lows- Still Up 9% YTD

(See Full Article in Seeking Alpha 3/26) Biopharmaceutical Downdraft 15% From February Highs (IBB$239) Large Cap Biopharmaceutical Stocks Are Core Holdings: ABBV, AMGN, GILD The biotech frenzy of MoMo investing is over so it is time to invest longer term with quality companies. If the sector can hold at February lows, even treading water could […]

Comments Off Continue Reading →